Back to Search
Start Over
HBx-induced degradation of Smc5/6 complex impairs homologous recombination-mediated repair of damaged DNA.
- Source :
-
Journal of hepatology [J Hepatol] 2022 Jan; Vol. 76 (1), pp. 53-62. Date of Electronic Publication: 2021 Aug 31. - Publication Year :
- 2022
-
Abstract
- Background & Aims: HBV causes hepatocellular carcinoma (HCC). While it was recently shown that the ability of HBV X protein (HBx) to impair the Smc5/6 (structural maintenance of chromosome 5/6) complex is important for viral transcription, HBx is also a potent driver of HCC. However, the mechanism by which HBx expression induces hepatocarcinogenesis is unclear.<br />Methods: Degradation of the Smc5/6 complex and accumulation of DNA damage were observed in both in vivo and in vitro HBV infection models. Rescue experiments were performed using nitazoxanide (NTZ), which inhibits degradation of the Smc5/6 complex by HBx.<br />Results: HBx-triggered degradation of the Smc5/6 complex causes impaired homologous recombination (HR) repair of DNA double-strand breaks (DSBs), leading to cellular transformation. We found that DNA damage accumulated in the liver tissue of HBV-infected humanized chimeric mice, HBx-transgenic mice, and human tissues. HBx suppressed the HR repair of DSBs, including that induced by the CRISPR-Cas9 system, in an Smc5/6-dependent manner, which was rescued by restoring the Smc5/6 complex. NTZ restored HR repair in, and colony formation by, HBx-expressing cells.<br />Conclusions: Degradation of the Smc5/6 complex by HBx increases viral transcription and promotes cellular transformation by impairing HR repair of DSBs.<br />Lay Summary: The hepatitis B virus expresses a regulatory protein called HBV X protein (or HBx). This protein degrades the Smc5/6 complex in human hepatocytes, which is essential for viral replication. We found that this process also plays a key role in the accumulation of DNA damage, which contributes to HBx-mediated tumorigenesis.<br />Competing Interests: Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.<br /> (Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Carcinoma, Hepatocellular complications
Carcinoma, Hepatocellular pathology
Disease Models, Animal
Liver drug effects
Liver pathology
Liver Neoplasms complications
Liver Neoplasms pathology
Mice
Recombinational DNA Repair immunology
Statistics, Nonparametric
Cell Cycle Proteins adverse effects
Chromosomal Proteins, Non-Histone adverse effects
Recombinational DNA Repair drug effects
Trans-Activators drug effects
Viral Regulatory and Accessory Proteins drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1600-0641
- Volume :
- 76
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of hepatology
- Publication Type :
- Academic Journal
- Accession number :
- 34478763
- Full Text :
- https://doi.org/10.1016/j.jhep.2021.08.010